DOI 10.1016/j.ijcard.2026.134431
Addition of high-sensitivity troponin to the T-Amylo score for the diagnosis of transthyretin cardiac amyloidosis in acute heart failure: TnT-Amylo.
Аннотация
BACKGROUND
Identifying specific aetiologies during hospitalization for acute heart failure (AHF) remains challenging, particularly conditions with important therapeutic and prognostic implications such as transthyretin cardiac amyloidosis (ATTR-CM). Clinical risk scores may aid early suspicion; however, many patients are classified as intermediate risk, limiting bedside decision-making in the acute care setting. High-sensitivity cardiac troponin T (hs-TnT) may improve diagnostic stratification.
METHODS
We conducted a prospective single-centre study including consecutive patients aged ≥60 years hospitalized with AHF between 2022 and 2024. All patients underwent bone-tracer scintigraphy; ATTR-CM was defined by myocardial uptake grade ≥ 2 and exclusion of plasma cell dyscrasia. The T-Amylo score was calculated blinded to diagnosis. hs-TnT was incorporated into a revised model (TnT-Amylo) using regression-derived weighting. Patients were categorized as low (0-2), intermediate (3-6), or high (7-11) risk. Diagnostic performance and reclassification were evaluated.
RESULTS
Among 138 patients (63% male; mean age 80 ± 6.9 years), ATTR-CM prevalence was 15.9%. The T-Amylo score showed good discrimination (AUC 0.93). hs-TnT was significantly higher in ATTR-CM than in non-ATTR-CM patients (median 68 vs 29 ng/L; p < 0.001; AUC 0.80). In the intermediate-risk group (n = 87), hs-TnT reclassified 15.7% to high risk (72.7% ATTR-CM) and 84.3% to low risk (5% ATTR-CM). The TnT-Amylo model achieved 72.3% sensitivity and 94.9% specificity, with a net reclassification improvement of 135%.
CONCLUSIONS
In AHF patients, integrating hs-TnT into a clinical risk score improves bedside diagnostic stratification, particularly among intermediate-risk patients. This approach may facilitate early aetiological identification and more efficient use of advanced imaging in the acute cardiovascular care setting.
TRANSLATIONAL PERSPECTIVE: This study translates pathophysiological insights of chronic myocardial injury in transthyretin cardiac amyloidosis into a simple bedside diagnostic tool. By integrating high-sensitivity cardiac troponin T-an inexpensive and universally available biomarker-into a clinical risk score, this approach bridges mechanistic myocardial damage with pragmatic decision-making, facilitating early identification of ATTR-CM and more efficient allocation of advanced imaging resources in acute heart failure care.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.